Literature DB >> 7824141

A large pedigree with early-onset Alzheimer's disease: clinical, neuropathologic, and genetic characterization.

D Campion1, A Brice, D Hannequin, S Tardieu, B Dubois, A Calenda, E Brun, C Penet, J Tayot, M Martinez.   

Abstract

We present clinical, neuropsychological, and neuropathologic data on a large pedigree including 34 subjects with early-onset progressive dementia. The mean (+/- SD) age at onset was 46 +/- 3.5 years and the mean age at death 52.6 +/- 5.7 years. Twelve patients were clinically diagnosed as having probable Alzheimer's disease (AD) according to the NINCDS-ADRDA criteria. Neuropsychological evaluation, performed at a moderate stage of the disease, was available in six subjects and showed a classic pattern of cognitive deficit. Myoclonus and extrapyramidal signs were common, and seizures were present in all affected subjects. There were neuropathologic changes typical of AD in two brains. A significant lod score of 5.48 was observed at a recombination fraction of theta = 0.0 with the genetic marker D14S43, thereby establishing that the responsible gene was located on chromosome 14q24.3. These results suggest that epilepsy could represent a particular feature in AD families linked to chromosome 14q.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7824141     DOI: 10.1212/wnl.45.1.80

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  11 in total

Review 1.  Genetics, transcriptomics, and proteomics of Alzheimer's disease.

Authors:  Andreas Papassotiropoulos; Michael Fountoulakis; Travis Dunckley; Dietrich A Stephan; Eric M Reiman
Journal:  J Clin Psychiatry       Date:  2006-04       Impact factor: 4.384

2.  Apolipoprotein E genotype does not affect age at onset in patients with chromosome 14 encoded Alzheimer's disease.

Authors: 
Journal:  J Med Genet       Date:  1996-02       Impact factor: 6.318

3.  Dementia: continuum or distinct entity?

Authors:  Glenn D Walters
Journal:  Psychol Aging       Date:  2010-09

4.  Early-onset autosomal dominant Alzheimer disease: prevalence, genetic heterogeneity, and mutation spectrum.

Authors:  D Campion; C Dumanchin; D Hannequin; B Dubois; S Belliard; M Puel; C Thomas-Anterion; A Michon; C Martin; F Charbonnier; G Raux; A Camuzat; C Penet; V Mesnage; M Martinez; F Clerget-Darpoux; A Brice; T Frebourg
Journal:  Am J Hum Genet       Date:  1999-09       Impact factor: 11.025

5.  Specific Silencing of L392V PSEN1 Mutant Allele by RNA Interference.

Authors:  Malgorzata Sierant; Alina Paduszynska; Julia Kazmierczak-Baranska; Benedetta Nacmias; Sandro Sorbi; Silvia Bagnoli; Elzbieta Sochacka; Barbara Nawrot
Journal:  Int J Alzheimers Dis       Date:  2011-04-07

6.  Treatment of epilepsy for people with Alzheimer's disease.

Authors:  Jia Liu; Lu-Ning Wang
Journal:  Cochrane Database Syst Rev       Date:  2021-05-11

Review 7.  Clinical phenotypic heterogeneity of Alzheimer's disease associated with mutations of the presenilin-1 gene.

Authors:  A J Larner; M Doran
Journal:  J Neurol       Date:  2005-11-04       Impact factor: 6.682

8.  Treatment of epilepsy for people with Alzheimer's disease.

Authors:  Jia Liu; Lu-Ning Wang; Li-Yong Wu; Yu-Ping Wang
Journal:  Cochrane Database Syst Rev       Date:  2018-12-20

Review 9.  Mutations, associated with early-onset Alzheimer's disease, discovered in Asian countries.

Authors:  Eva Bagyinszky; Young Chul Youn; Seong Soo A An; SangYun Kim
Journal:  Clin Interv Aging       Date:  2016-10-17       Impact factor: 4.458

10.  Pooled-DNA sequencing identifies novel causative variants in PSEN1, GRN and MAPT in a clinical early-onset and familial Alzheimer's disease Ibero-American cohort.

Authors:  Sheng Chih Jin; Pau Pastor; Breanna Cooper; Sebastian Cervantes; Bruno A Benitez; Cristina Razquin; Alison Goate; Carlos Cruchaga
Journal:  Alzheimers Res Ther       Date:  2012-08-20       Impact factor: 6.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.